Zacks' 7 Best Stocks for June, 2013
FREE Report for Zacks.com
Visitors Only

They're hand-picked from the list of Zacks Rank #1 Strong Buys. Our experts predict that their prices will jump the soonest.

Today, you can see them free.

Close This Panel X

Are you a new Zacks Member or a visitor to Zacks.com?

Recent Quotes

No Recent Quote currently available

My Portfolio

My Portfolio Tracker

One of the most important steps you can take today is to set up your portfolio tracker on Zacks.com. Once you do, you'll be notified of major events affecting your stocks and/or funds with daily email alerts. Set yours up today.

More Zacks Resources

Zacks Rank Home - Evaluate your stocks and use the Zacks Rank to eliminate the losers and keep the winners.

Mutual Fund Rank Home - Evaluate your funds with the Mutual Fund Rank for both your personal and retirement funds.

Stock/Mutual Fund Screening - Find better stocks and mutual funds. The ones most likely to beat the market and provide a positive return.

My Portfolio - Track your Portfolio and find out where your stocks/mutual funds stack up with the Zacks Rank.

Zacks #1 Stocks on the Move 05/20/2013

Company Name Symbol %Change
ORBOTECH LTD ORBK
10.86%
NOAH HOLDING NOAH
9.92%
SONIC FOUNDR SOFO
9.45%
VIPSHOP HOLD VIPS
9.20%
RENEWABLE EN REGI
8.98%

P&G's Analyst Day Update

by Zacks Equity Research

November 19, 2012 | Comments : 0 Recommended this article: (0)

This page is temporarily not available.  Please check later as it should be available shortly. If you have any questions, please email customer support at support@zacks.com or call 800-767-3771 ext.  9339.

In the recently-held analyst day meeting, Procter & Gamble Company ( PG - Analyst Report ) reaffirmed its previously-provided outlook, highlighted potential for higher share repurchases, announced further job cuts and discussed its innovation pipeline.

Innovation Plans

Innovation is the driving force for P&G and the company has a strong tradition of not only introducing blockbuster new products but also creating entirely new categories. However, P&G has failed to launch any game-changing product in the recent past. At the call, the company announced plans to boost discontinuous innovations; which are breakthrough innovations of existing products.

The company also highlighted some present and upcoming product launches during the call. Some recent successful product launches include Tide Pods, Downy Unstoppables diapers, ZzzQuil sleeping aid product, Pro Health for Life oral care line and some new prestige fragrances among others. Some upcoming product launches include Cascade Platinum dishwasher in U.S, a new line of Olay skin care products, Vidal Sassoon Professional Series hair care products, Fusion Mach3 sensitive and disposable skin products. All of these are scheduled to be launched in January.

Further Job Cuts

P&G maintained that its productivity and cost savings plan will generate $10 billion in cost reductions by the end of fiscal 2016. P&G’s plan also include a workforce reduction of 5,700 by the end of fiscal 2013. The plan was announced in February 2012 and aims to reduce spending across all areas like supply chain, research & development, marketing and overheads. The plan also includes improving net manufacturing productivity by 5% annually.

Till the end of October, the company had reduced around 4,700 positions, which is almost 80% of its target. On top of the current plans, P&G plans to further reduce non-manufacturing jobs by an additional 2% to 4% per year from fiscal 2014 through 2016.

Improved Share Repurchase Outlook

P&G hiked its share repurchase expectations from $4 billion to the range of $4 billion-$6 billion. Moreover, if cash generation remains strong, P&G believes it should be able to meet the top end of the guidance. The company expects to repurchase stock worth $4 billion by the end of fiscal second quarter.

Outlook Reaffirmed

The consumer giant reaffirmed its second quarter and fiscal 2013 guidance provided during the first quarter conference call held late last month.

Management continues to expect organic sales to grow in the range of 2% to 4%. Net revenue is expected to remain flat or increase upto 1% from 2012 levels. Currency is expected to hurt revenues by 2% to 3%. Pricing is expected to add 2 percentage points to top-line growth.

The company also maintained its previously provided core earnings guidance range of $3.80-$4.00, which represents a year-over-year movement of a negative 1% to a positive 4%. However, adjusting for headwinds from pension and benefit plans and import restrictions in Argentina and mandated price reductions in Venezuela, earnings are expected to grow in the range of 2%-7%. Capital expenditure is expected to be around 5.5% of sales in fiscal 2013.

For the second quarter of fiscal 2013, the company expects revenues to range between negative 1% to a positive 1%. Organic sales are expected to grow between 1% and 3%. Foreign exchange is expected to hurt revenue growth by 2%. Core earnings are expected to remain in the range of $1.07 to $1.13, representing a movement in the range of negative 2% to positive 4%. The core earnings guidance includes gains related to the divestiture of P&G’s bleach business in Italy.

Our Recommendation

We currently have a long-term Neutral recommendation on P&G. However, the stock carries a Zacks #3 Rank (a short-term Hold rating). A peer company Kimberly Clark Corporation ( KMB - Analyst Report ) carries a better rank, Zacks #2 ( a short-term ‘Buy’ rating).

P&G’s first quarter results were better than expectations. Slowdown in developed nations and commodity cost increases resulted in a series of disappointing earnings results and guidance cuts for P&G. However, the fourth quarter 2012 and first quarter 2013 results were much better than past quarters. Overall, we are encouraged by P&G’s strong brand recognition, diversified portfolio, rapid growth in developing nations, impressive product development capabilities and marketing prowess.

Fiscal 2012 was a tough year for P&G and the company plans to implement some meaningful changes to re-accelerate its top and bottom-line growth keeping in pace with the peer companies. The company has laid out plans to improve results in developed markets while maintaining momentum in the developing nations. Moreover, the company will increase focus on the most profitable business, its biggest innovations and further accelerate cost savings. We would prefer to wait and see substantial results from the turnaround efforts.

Email Print Share Rate Pos Rate Neg

Read/Post Comments (0) | Recommended this article (0)

Please login to Zacks.com or register to post a comment.

Zacks Research is Reported On:

Zacks Investment Research

is an A+ Rated BBB

Accredited Business.